Colorectal. The Latest Advances to Improve Adenoma Detection Rates. Sunday, October 15, 2017

Transcription

1 Presorted First Class Mail US Postage PAID Permit # 906 Bellmawr NJ Cancer Prevention Distinguished Indiana University Indianapolis, IN University of Kansas School of Medicine Kansas City, MO Editor in Chief Gastrointestinal Endoscopy Mayo Clinic Jacksonville, FL Associate Professor of Clinical Medicine, UCSF Division of Gastroenterology, Department of Medicine San Francisco Veterans Affairs Medical Center San Francisco, CA 6900 Grove Road Building 100 7:30 pm 8:00 pm Registration & Dinner 8:00 pm 9:30 pm CME-certified Symposium 7:30 pm 8:00 pm Registration & Dinner This continuing activity is provided by Supported by an educational grant from Aries Pharmaceuticals Inc. This event is neither sponsored by nor endorsed by ACG or WGO.

2 OVERVIEW cancer (CRC) is the third most common type of cancer worldwide and second deadliest form of cancer in the United States. Current estimates suggest that up to 25% of adenomas are missed with current colonoscopy technologies, primarily due to poor visualization in folds and other difficult-to-detect areas. Technological advances in recent years have improved detection rates. This CME activity will review appropriate screening and prevention efforts for the early detection of patients with CRC, as well as evaluate the clinical safety and efficacy of new and emerging technologies for the detection of lesions in patients undergoing colonoscopy for CRC screening. LEARNING OBJECTIVES Upon successful completion of this activity, participants should be better able to: Review importance of appropriate screening and prevention efforts for the early detection of patients with colorectal cancer. Examine the benefits and limitations of current methods for colon cancer detection. Assess the impact of adenoma detection rates on colorectal cancer outcomes. Evaluate the clinical safety and efficacy of new and emerging technologies for the detection of lesions in patients undergoing colonoscopy for CRC screening istockphoto.com/ MicrovOne; berya113; maclifethai TARGET AUDIENCE The intended audience for the activity is gastroenterologists and other health care professionals involved in the treatment of patients with colorectal cancer.

3 AGENDA 7:30 pm 8:00 pm Registration and Dinner 8:00 pm 8:10 pm Introduction and Pretest 8:10 pm 8:25 pm and Cancer Outcomes 8:25 pm 8:45 pm Non-device Tools for Adenoma Detection Rates 8:45 pm 9:05 pm Devices to Maximize 9:05 pm 9:15 pm Case Discussion 9:15 pm 9:30 pm Posttest and Question and Answer Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing for physicians. Vindico Medical Education designates this live activity for a maximum of AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity. In accordance with the Accreditation Council for Continuing Medical Education s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience., topics, program schedule, and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program committee.

4 Presorted First Class Mail US Postage PAID Permit # 906 Bellmawr NJ Cancer Prevention Distinguished Indiana University Indianapolis, IN University of Kansas School of Medicine Kansas City, MO Editor in Chief Gastrointestinal Endoscopy Mayo Clinic Jacksonville, FL Associate Professor of Clinical Medicine, UCSF Division of Gastroenterology, Department of Medicine San Francisco Veterans Affairs Medical Center San Francisco, CA 6900 Grove Road Building 100 7:30 pm 8:00 pm Registration & Dinner 8:00 pm 9:30 pm CME-certified Symposium 7:30 pm 8:00 pm Registration & Dinner This continuing activity is provided by Supported by an educational grant from Aries Pharmaceuticals Inc. This event is neither sponsored by nor endorsed by ACG or WGO.

5 7:30 pm 8:00 pm Registration & Dinner Register Online! VindicoCME.com/ Pre-registration is encouraged but not required. Seating to be based on arrival order; early arrival is recommended. Contact Information: Toll-free: , ext. 219 or 476 Phone: , ext. 219 or 476 Fax: Mail: Registration Department 6900 Grove Road First Name M.I. Last Name Preferred Mailing Address (Home/Business) City State Zip Code Country Daytime Phone Evening Phone Fax Date of Birth (for confirmation purposes) (for confirmation purposes) (for tracking credits ONLY) National Provider Identifier (NPI) Medical License Number Medical License State Degree (please specify) q MD/DO q PhD q NP/PA q RN/MSN/BSN q RPh/PharmD q Industry q Other: Specialty (select one) q Gastroenterology q Pharmacy q Nursing q Internal Medicine q Oncology q Other: How did you hear about this meeting? (multiple selections allowed) q Advertisement q Brochure q q Postcard q Web site q Word of mouth CME Activity Request q YES, I would like to receive information regarding future CME activities related to this therapeutic area. ADA compliance: In compliance with the Americans with Disabilities Act of 1990, we will make reasonable efforts to accommodate persons with disabilities. Please call with your requests. Priority Code:

6 Presorted First Class Mail US Postage PAID Permit # 906 Bellmawr NJ Cancer Prevention Distinguished Indiana University Indianapolis, IN University of Kansas School of Medicine Kansas City, MO Editor in Chief Gastrointestinal Endoscopy Mayo Clinic Jacksonville, FL Associate Professor of Clinical Medicine, UCSF Division of Gastroenterology, Department of Medicine San Francisco Veterans Affairs Medical Center San Francisco, CA 6900 Grove Road Building 100 7:30 pm 8:00 pm Registration & Dinner 8:00 pm 9:30 pm CME-certified Symposium 7:30 pm 8:00 pm Registration & Dinner This continuing activity is provided by Supported by an educational grant from Aries Pharmaceuticals Inc. This event is neither sponsored by nor endorsed by ACG or WGO.